Darifenacin Impurity 3

(2R,3R)-2,3-dihydroxybutanedioic acid;|(3S)-α,α-Diphenyl-3-pyrrolidineacetamide (2R,3R)-2,3-Dihydroxybutanedioate;|(S)-2-(3-Pyrrolidinyl)-2,2-diphenylacetamide L-tartrate ;|(S)-2,2-Diphenyl-2-(pyrrolidin-3-yl)acetamide (2R,3R)-2,3-dihydroxysuccinate;|(S)-2,2-Diphenyl-2-(pyrrolidine-3-yl)acetamide L-tartrate ;|(S)-3-(1-Carbamoyl-1,1-diphenylmethyl)pyrrolidine L-Tartrate;|2,2- diphenyl-2-[(3S)-pyrrolidin-3-yl]acetamide;|3-(S)-(+)-(1-Carbamoyl-1,1-diphenylmethyl)pyrrolidine L-(+)-Tartrate;|3-(S)-(+)-(1-Carbamoyl-1,1-diphenylmethyl)pyrroloidine-L-(+)-tartarate.;|CS-O-07755|Darifenacin Pyrrolidine Impurity S-Isomer ;|Darifenacin Pyrrolidine Impurity S-Isomer ; (S)-2-(3-Pyrrolidinyl)-2,2-diphenylacetamide L-tartrate ; (S)-2,2-Diphenyl-2-(pyrrolidine-3-yl)acetamide L-tartrate|Darifenacin Pyrrolidine Impurity S-Isomer;